Publications by authors named "Yuankui Zhu"

Acute liver failure (ALF) is a complex syndrome that impairs the liver's function to detoxify bilirubin, ammonia, and other toxic metabolites. Bioartificial liver (BAL) aims to help ALF patients to pass through the urgent period by temporarily undertaking the liver's detoxification functions and promoting the recovery of the injured liver. We genetically modified the hepatocellular cell line HepG2 by stably overexpressing genes encoding UGT1A1, OATP1B1, OTC, ARG1, and CPS1.

View Article and Find Full Text PDF

LAG3 is an inhibitory immune checkpoint expressed on activated T and NK cells. Blocking the interaction of LAG3 with its ligands MHC-II and FGL1 renders T cells improved cytotoxicity to cancer cells. Current study generated a panel of LAG3 monoclonal antibodies (mAbs) through immunization of mice followed by phage display.

View Article and Find Full Text PDF

Chimeric antigen receptor (CAR)-modified T cell therapy has achieved remarkable efficacy in treating hematological malignancies, but it confronts many challenges in treating solid tumors, such as the immunosuppressive microenvironment of the solid tumors. These factors reduce the antitumor activity of CAR-T cells in clinical trials. Therefore, we used the immunocytokine interleukin-12 (IL-12) to enhance the efficacy of CAR-T cell therapy.

View Article and Find Full Text PDF

Background: Chimeric antigen receptor (CAR) T cell therapy has shown promising results in treating blood cancers, but it has limited efficacy against solid tumors that express mesothelin (MSLN). One of the reasons is the immunosuppressive tumor microenvironment, which consists of physical barriers, multiple mechanisms of immune evasion, and various biochemical factors that favor tumor growth and survival. These factors reduce the antitumor activity of MSLN-targeted CAR T cells in clinical trials.

View Article and Find Full Text PDF

Backgroud: Macrobrachium rosenbergii is an economically important species that is widely cultivated in some Asian nations. Foxl2 is a transcriptional regulator of ovarian differentiation and development. The aim of this study was to study the bioinformatics features and expression patterns of M.

View Article and Find Full Text PDF
Article Synopsis
  • Glypican-3 (GPC3) is a promising target for immunotherapy in liver cancer, with new chicken monoclonal antibodies (mAbs) developed to enhance the effectiveness of antibody-drug conjugates (ADCs).
  • A large panel of these mAbs showed very high affinity for GPC3, with the best mAb being 40 times more potent than previously known options, and they were also stable at high temperatures.
  • Among the immunotoxins created from these mAbs, one (J80A-PE24) was significantly more potent in reducing tumor growth compared to existing treatments, and when combined with another drug, it showed an even greater tumor-shrinking effect.
View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is a major cause of cancer deaths worldwide, and there is no effective treatment for its advanced stages.
  • This study investigates the effectiveness of six bispecific antibodies targeting Glypican-3 (GPC3), used alone or with the chemotherapy drug Irinotecan, for treating HCC.
  • Results show that a specific antibody combination, hYP7-OKT3-hFc, was the most effective in killing GPC3-positive cancer cells and significantly improved tumor growth control when used with Irinotecan in mouse models.
View Article and Find Full Text PDF

Targeting inhibitory immune checkpoint molecules has significantly altered cancer treatment regimens. T cell immunoglobulin and mucin domain 3 (TIM3) is one of the major inhibitory immune checkpoints expressed on T cells. Blocking the engagement of TIM3 and its inhibitory ligand galectin-9 may potentiate the effects of immunotherapy or overcome the adaptive resistance to the therapeutic blockade of programmed cell death protein 1, cytotoxic T-lymphocyte-associated protein 4, B- and T-lymphocyte attenuator and lymphocyte-activation gene 3, amongst others, as each of these immune checkpoints harbors unique properties that set it apart from the rest.

View Article and Find Full Text PDF

Background: Small cell lung cancer (SCLC) accounts for 15% of lung cancers, and the primary treatment of this malignancy is chemotherapy and radiotherapy. Delta-like 3 (DLL3) is an attractive target for SCLC immunotherapy since its expression is highly restricted to SCLC with a neglectable appearance on normal adult tissues. In the current study, we aimed to explore the efficacy of DLL3-targeted SCLC immunotherapy via the engagement of T cell.

View Article and Find Full Text PDF

Background: The experiment evaluated the effect of nutrition levels and sex on the growth performance, carcass characteristics and meat quality of F1 Angus × Chinese Xiangxi yellow cattle.

Methods: During the background period of 184 d,23 steers and 24 heifers were fed the same ration,then put into a 2 × 2 × 2 factorial arrangement under two levels of - dietary energy (TDN: 70/80% DM), protein (CP: 11.9/14.

View Article and Find Full Text PDF